TY - JOUR
T1 - The Epidemiology of Psychedelic Use Among United States Military Veterans
AU - Davis, Alan K.
AU - Bates, Mark
AU - Lund, Erik M.
AU - Sepeda, Nathan D.
AU - Levin, Adam W.
AU - Armstrong, Stacey B.
AU - Koffman, Robert
AU - Hooyer, Katinka
AU - Yehuda, Rachel
N1 - Publisher Copyright:
© 2024 The Author(s). Published with license by Taylor & Francis Group, LLC.
PY - 2024
Y1 - 2024
N2 - We sought to identify patterns of psychedelic use among United States military veterans, compare demographic variables and perspectives of those who did and did not report use, and characterize benefits and adverse outcomes associated with use. Respondents (N = 426) were recruited to complete an online cross-sectional survey. Approximately one-half (51%) reported using psychedelics. Most did so for healing/treatment (70%) and/or spiritual purposes (48%), and most (85%) reported benefiting from use. Those who used psychedelics reported they would be more likely to use VA services (p <.001, d = 0.64) and to return to the VA for care (p <.001, d = 0.79) if psychedelic therapy was offered. Almost two-thirds (59%) reported adverse outcomes associated with use. Equivalent proportions rated their psychedelic experiences as beneficial among those who did (89%) and did not (81%) report adverse outcomes. Fewer adverse outcomes were associated with being older, using psilocybin, feeling prepared and confident in the reasons for use, being in a comfortable setting, and being able to “trust, let go, and be open” (Rc = 0.77; p <.001). Psychedelics may offer benefits but may also lead to adverse outcomes without proper preparation and support. Future research should examine the utility of psychedelic-based approaches for veteran mental health care.
AB - We sought to identify patterns of psychedelic use among United States military veterans, compare demographic variables and perspectives of those who did and did not report use, and characterize benefits and adverse outcomes associated with use. Respondents (N = 426) were recruited to complete an online cross-sectional survey. Approximately one-half (51%) reported using psychedelics. Most did so for healing/treatment (70%) and/or spiritual purposes (48%), and most (85%) reported benefiting from use. Those who used psychedelics reported they would be more likely to use VA services (p <.001, d = 0.64) and to return to the VA for care (p <.001, d = 0.79) if psychedelic therapy was offered. Almost two-thirds (59%) reported adverse outcomes associated with use. Equivalent proportions rated their psychedelic experiences as beneficial among those who did (89%) and did not (81%) report adverse outcomes. Fewer adverse outcomes were associated with being older, using psilocybin, feeling prepared and confident in the reasons for use, being in a comfortable setting, and being able to “trust, let go, and be open” (Rc = 0.77; p <.001). Psychedelics may offer benefits but may also lead to adverse outcomes without proper preparation and support. Future research should examine the utility of psychedelic-based approaches for veteran mental health care.
KW - Epidemiology, adverse outcomes
KW - mental health
KW - psychedelic
KW - veterans
UR - http://www.scopus.com/inward/record.url?scp=85203684155&partnerID=8YFLogxK
U2 - 10.1080/02791072.2024.2401977
DO - 10.1080/02791072.2024.2401977
M3 - Article
AN - SCOPUS:85203684155
SN - 0279-1072
JO - Journal of Psychoactive Drugs
JF - Journal of Psychoactive Drugs
ER -